Back to the main directory
EarningsReview / Equity
- Will Q3 LFL rebound suffice to support FY guidance? by BNP Paribas Exane
- 360 Report | Opus Group | Hold | Making the world cleaner and safer by Kepler Cheuvreux
- Hedging Trade War Tail Risk by BNP Paribas Exane
- Fire claims set to continue in Q3 by DnB Markets
- Investment Daily 05/10/2018 by BNP Paribas Exane
- Exane Satellite Reader Digest by BNP Paribas Exane
- What the SRI investor should have read by BNP Paribas Exane
- Klövern (Hold, TP: SEK11.60) - Bid for Agora by DnB Markets
- Interest rate pressure, a bid, investments and house prices by DnB Markets
- Espresso | Casino | Buy | Q3 sales preview by Kepler Cheuvreux
- Outlook for shopping centres - our survey says... by BNP Paribas Exane
- Swedish Orphan Biovitrum (Buy, TP: SEK360.00) - Elocta versus Hemlibra by DnB Markets
- Borregaard (Buy, TP: NOK90.00) - Lignin oversupply looks priced in by DnB Markets
- Weekly NAV update by DnB Markets
- Espresso | Kering | Buy | Preview of Q3 sales by Kepler Cheuvreux
- AcadeMedia AB (Buy, TP: SEK82.00) - Continued strong student growth by DnB Markets
- 360 Report | Elkem | Buy | Still room for dessert by Kepler Cheuvreux
- Q3s: 2019 coming into focus by BNP Paribas Exane
- ABB (Buy, TP: SEK256.00) - Don’t stop believin’ by DnB Markets
- INVEST SECURITIES - Carmat : Calendrier clinique confirmé - NEUTRE, OC 27€ by Invest Securities
- Spectrum (Sell, TP: NOK36.00) - Another miss by DnB Markets
- Shelf Drilling (Buy, TP: NOK100.00) - Building backlog into 2021 by DnB Markets
- 22% more scrubbers for 2020e by DnB Markets
- What''s priced in? by BNP Paribas Exane
- In The Flow by BNP Paribas Exane
- Espresso | Givaudan | Hold | Q3 trading and upcoming investor days by Kepler Cheuvreux
- Feeling deflated by BNP Paribas Exane
- Feedback from Le Bourget by BNP Paribas Exane
- Another warning, CEO steps down by BNP Paribas Exane
- Skistar (Hold, TP: SEK259.00) - Not about to hit the slopes by DnB Markets
- Skistar (Hold, TP: SEK259.00) - Not about to hit the slopes by DnB Markets
- SAS (Buy, TP: SEK30.00) - September traffic statistics by DnB Markets
- Espresso | Carrefour | Hold | Q3 sales preview by Kepler Cheuvreux
- Novo Nordisk (Buy, TP: DKK380.00) - Eli Lilly steals the show at EASD by DnB Markets
- Never discount retail MandA by BNP Paribas Exane
- Hambach profit warning by BNP Paribas Exane
- Kongsberg Gruppen (No_rec, TP: NOK) - Still-solid contract potential by DnB Markets
- Industrivärden (Hold, TP: SEK205.00) - Less short-term appeal by DnB Markets
- Guidance looks challenging by BNP Paribas Exane
- What happened in Vegas by BNP Paribas Exane
- Tele2 (Hold, TP: SEK117.00) - Awaiting regulatory approval by DnB Markets
- What is management saying? by BNP Paribas Exane
- Kering: The Key Investment Controversy by BNP Paribas Exane
- Investment Daily 08/10/2018 by BNP Paribas Exane
- TGS Nopec (Hold, TP: NOK314.00) - First miss since Q1 2017 by DnB Markets
- Ambu (Buy, TP: DKK270.00) - CMD: growth to reach new heights by DnB Markets
- Non-premium all-stock M&A by DnB Markets
- Sales hit by weaker end markets by BNP Paribas Exane
- Pareto Bank (Buy, TP: NOK50.00) - Set for another strong quarter by DnB Markets
- Downside now appears limited; upgrading to Neutral by BNP Paribas Exane